Speaker Profile

Melanie Matheu

Biography

Dr. Matheu founded Prellis Biologics in October 2016 with a vision to create fully vascularized human tissues and organs for transplantation. Melanie’s combined PhD-level specialties in laser-based microscopy, Immunology, Chemistry, Physiology, and Biophysics have allowed her to bridge the gap between seemingly disparate fields to make real human organ engineering a reality. During her academic career Dr. Matheu authored numerous peer-reviewed publications and a book chapter detailing methods and approaches for high-resolution imaging in tissues. Melanie was inspired to find a way to reverse-engineer laser based imaging systems into a printer when she realized that the final road-block in building human organs for transplant was a simple and well-defined engineering problem: How can microvasculature be printed fast enough to build human tissues? Prellis Biologics has solved this problem and is bringing real tissue engineering solutions to the pharmaceutical R&D market.

Clinical & Research Tools Showcase: Prellis Biologics
Two-dimensional cell culture hasn’t changed for over 100 years, is time consuming, and often yields erroneous results that can’t be repeated in vivo. Complex in vitro or 3D cell culture more closely replicates physiology and is the future of improved therapeutics screening.

3D Cell Culture: The Next Drug Discovery Revolution
Two-dimensional cell culture hasn’t changed for over 100 years, is time consuming, and often yields erroneous results that can’t be repeated in vivo. Complex in vitro or 3D cell culture more closely replicates physiology and is the future of improved therapeutics screening.